We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
-$1.95B
Cap. Flow
-$2.01B
Cap. Flow %
-182.11%
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$38.7M
2
SE icon
Sea Limited
SE
+$29.1M
3
MELI icon
Mercado Libre
MELI
+$27M
4
META icon
Meta Platforms (Facebook)
META
+$19.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$17.2M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.32B
2
JD icon
JD.com
JD
+$301M
3
BIDU icon
Baidu
BIDU
+$279M
4
NTES icon
NetEase
NTES
+$202M
5
TCOM icon
Trip.com Group
TCOM
+$77.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.58%
2 Technology 17.59%
3 Communication Services 16.9%
4 Healthcare 11.23%
5 Real Estate 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
226
Baidu
BIDU
$35.8B
$307K 0.03%
2,064
-2,109,040
-100% -$279M
ALGN icon
227
Align Technology
ALGN
$12B
$304K 0.03%
1,286
+115
+10% +$35.3K
PM icon
228
Philip Morris
PM
$301B
$304K 0.03%
3,078
+41
+1% +$4.18K
AGIO icon
229
Agios Pharmaceuticals
AGIO
$2.16B
$303K 0.03%
13,673
+4,750
+53% +$107K
NEE icon
230
NextEra Energy
NEE
$187B
$302K 0.03%
3,901
+73
+2% +$5.56K
CTIC
231
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$300K 0.03%
+50,171
New +$257K
ENTA icon
232
Enanta Pharmaceuticals
ENTA
$372M
$299K 0.03%
6,320
+3,430
+119% +$186K
SWKS icon
233
Skyworks Solutions
SWKS
$9.06B
$299K 0.03%
3,225
-48
-1% -$5.18K
T icon
234
AT&T
T
$165B
$298K 0.03%
14,215
-4,227
-23% -$84.3K
TGTX icon
235
TG Therapeutics
TGTX
$8.58B
$298K 0.03%
70,105
+39,622
+130% +$247K
WFC icon
236
Wells Fargo
WFC
$261B
$295K 0.03%
7,526
-252
-3% -$11.1K
CPRT icon
237
Copart
CPRT
$25.9B
$293K 0.03%
10,772
+308
+3% +$8.77K
INO icon
238
Inovio Pharmaceuticals
INO
$79.8M
$290K 0.03%
13,956
+7,014
+101% +$198K
VCEL icon
239
Vericel Corp
VCEL
$2.3B
$289K 0.03%
11,497
+5,228
+83% +$154K
LIN icon
240
Linde
LIN
$237B
$288K 0.03%
1,000
– –
LGND icon
241
Ligand Pharmaceuticals
LGND
$6.02B
$287K 0.03%
5,163
+1,317
+34% +$74.7K
ALLO icon
242
Allogene Therapeutics
ALLO
$601M
$285K 0.03%
25,006
-3,309
-12% -$29.4K
PTGX icon
243
Protagonist Therapeutics
PTGX
$8.75B
$285K 0.03%
36,033
+25,593
+245% +$309K
ROST icon
244
Ross Stores
ROST
$76.6B
$284K 0.03%
4,049
+51
+1% +$4.54K
RTX icon
245
RTX Corp
RTX
$287B
$284K 0.03%
2,953
+33
+1% +$3.17K
ENPH icon
246
Enphase Energy
ENPH
$4.84B
$278K 0.03%
1,422
-5
-0.4% -$904
CCL icon
247
Carnival Corporation Ltd
CCL
$36.1B
$277K 0.03%
32,016
+14,407
+82% +$211K
LCID icon
248
Lucid Motors
LCID
$2.46B
$273K 0.02%
1,593
+45
+3% +$8.55K
SANA icon
249
Sana Biotechnology
SANA
$885M
$273K 0.02%
42,452
+18,124
+74% +$115K
CI icon
250
Cigna
CI
$76.6B
$269K 0.02%
1,021
-100
-9% -$25.8K
8 9
10
11 12

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, E Fund Management held 359 positions worth $1.1B, down 64% from $3.06B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E Fund Management withdrew a net $2.01B in Q2 2022, closing 36 positions and reducing 93 holdings. Its most notable exit was Alibaba, an estimated $1.32B position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Sea Limited worth $22.9M.

  • E Fund Management's largest Q2 2022 buy was Sea Limited: 342,000 shares worth $22.9M.
  • E Fund Management added most to STAAR Surgical in Q2 2022, an estimated $38.7M increase.
  • E Fund Management's biggest Q2 2022 reduction was JD.com, cutting an estimated $301M.
  • E Fund Management fully exited Alibaba in Q2 2022, selling an estimated $1.32B.
  • E Fund Management's ten largest holdings make up 55% of its $1.1B portfolio in Q2 2022.
  • E Fund Management opened 34 new positions and closed 36 in Q2 2022.
  • E Fund Management's portfolio value fell 64% quarter-over-quarter to $1.1B.

Based on E Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.